hotspot -WSS

hotspot

author：explore 2025-08-11 16:24:53 - browse：84544

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

Scientists at the Food and Drug Administration have two big questions about Eli Lilly’s experimental Alzheimer’s drug donanemab ahead of a panel of outside experts that it is convening on Monday:

Should the patients who receive the medicine be limited based on PET scans of a protein called tau that Eli Lilly used as a key criteria for trying to determine whether they should receive the drug? That could reduce usage of the medicine by adding a barrier to its use.

And how do the potential risks of using the drug compare to its benefits? The FDA points to one analysis, admittedly with missing data, that could indicate patients who receive the drug have a higher risk of dying.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： What to watch for from Zogenix and Amicus clinical trials

focus

WSS

Gene therapy denied for Afghan refugee whose father aided U.S.

Will the FTC rein in IQVIA's health data empire?

Merck to acquire Harpoon Therapeutics for $680 million

Democrats decry new health bill for going easy on private equity

CDC Director Mandy Cohen on transparency, trust, and health

Medicare Advantage coverage denials need scrutiny, senators say

focus

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

focus

Virginia high school admissions case could be legal follow

What causes rare myocarditis in young men after Covid vaccines?

Dobbs anniversary: the lost opportunity of abortion as health care

Physician assistants need a new name. Here's what it should be

What does generative AI mean for health care? We asked experts

Fauci's latest grilling in Congress: 9 hours, behind closed doors

Affirmative action in medical school literally saved lives

Hospital chaplains balance Covid safety with patients’ spiritual needs

Medicare details structure of new drug price negotiation program

US economic growth accelerated in 2nd quarter, exceeding expectations and quieting recession fears

explore

JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK

Ascension's ugly legal battle over care for poor patients in Texas

Search called off for baby washed away in Pennsylvania flash flood

US economic growth accelerated in 2nd quarter, exceeding expectations and quieting recession fears

What causes rare myocarditis in young men after Covid vaccines?

New Alzheimer's drugs heat up race for early detection blood tests

focus

knowledge

Wikipedia

knowledge